<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <notes />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <amendments />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects />
      </billSubjects>
    </subjects>
    <version>1.0.0</version>
    <sponsors>
      <item>
        <identifiers>
          <gpoId>8270</gpoId>
          <lisID>1010</lisID>
          <bioguideId>S000033</bioguideId>
        </identifiers>
        <bioguideId>S000033</bioguideId>
        <lastName>SANDERS</lastName>
        <firstName>BERNARD</firstName>
        <fullName>Sen. Sanders, Bernard [I-VT]</fullName>
        <byRequestType />
        <middleName />
        <state>VT</state>
        <party>I</party>
      </item>
    </sponsors>
    <originChamber>Senate</originChamber>
    <calendarNumbers />
    <committeeReports />
    <latestAction>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <actionDate>2017-07-31</actionDate>
      <links />
    </latestAction>
    <recordedVotes />
    <relatedBills>
      <item>
        <type>HR</type>
        <latestAction>
          <text>Referred to the Subcommittee on Health.</text>
          <actionDate>2017-08-04</actionDate>
        </latestAction>
        <number>3536</number>
        <congress>115</congress>
        <latestTitle>To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</latestTitle>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2017-07-31</actionDate>
        <committee>
          <systemCode>sshr00</systemCode>
          <name>Health, Education, Labor, and Pensions Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>Senate</name>
          <code>0</code>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <type>IntroReferral</type>
        <actionDate>2017-07-31</actionDate>
        <links />
        <text>Introduced in Senate</text>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>10000</actionCode>
        <committee />
      </item>
      <actionTypeCounts>
        <referredToCommittee>1</referredToCommittee>
        <introducedInSenate>1</introducedInSenate>
      </actionTypeCounts>
      <actionByCounts>
        <senate>2</senate>
      </actionByCounts>
    </actions>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-07-31T22:48:42Z</date>
            </item>
          </activities>
          <chamber>Senate</chamber>
          <subcommittees />
          <name>Health, Education, Labor, and Pensions Committee</name>
          <systemCode>sshr00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <updateDate>2017-09-11T03:06:48Z</updateDate>
    <cboCostEstimates />
    <createDate>2017-08-01T00:26:48Z</createDate>
    <billType>S</billType>
    <cosponsors />
    <congress>115</congress>
    <introducedDate>2017-07-31</introducedDate>
    <summaries>
      <billSummaries />
    </summaries>
    <title>A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</title>
    <laws />
    <billNumber>1681</billNumber>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <chamberName />
        <chamberCode />
        <title>A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</title>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <chamberName />
        <chamberCode />
        <title>A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.</title>
      </item>
    </titles>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

